CLINICAL TRIALS PROFILE FOR NELOTANSERIN
✉ Email this page to a colleague
Clinical Trials for Nelotanserin
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT02640729 ↗ | Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia | Completed | Axovant Sciences Ltd. | Phase 2 | This study seeks to evaluate safety and efficacy of Nelotanserin for the treatment of visual hallucinations in subjects with Lewy body dementia. |
NCT02708186 ↗ | Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD) | Completed | Axovant Sciences Ltd. | Phase 2 | This study seeks to evaluate the safety and efficacy of Nelotanserin for the treatment of Rapid Eye Movement (REM) Sleep Behavior Disorder (RBD) in subjects with dementia with Lewy bodies (DLB) or Parkinson's disease dementia (PDD). |
NCT02871427 ↗ | Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder | Terminated | Axovant Sciences Ltd. | Phase 2 | This study seeks to evaluate the long-term safety and effectiveness of nelotanserin for the treatment of visual hallucinations (VHs) and Rapid Eye Movement (REM) Sleep Behavior Disorder (RBD) in subjects with Lewy body dementia (LBD). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Nelotanserin
Condition Name
Clinical Trial Locations for Nelotanserin
Trials by Country
Clinical Trial Progress for Nelotanserin
Clinical Trial Phase
Clinical Trial Sponsors for Nelotanserin
Sponsor Name